Literature DB >> 23740369

Stress and melanoma: increasing the evidence towards a causal basis.

Sudipta Sinnya1, Brian De'Ambrosis.   

Abstract

Melanoma is a multifactorial disease with a strong genetic component and known risk factors such as excessive ultraviolet exposure, intermittent sunburns and fair skin type. The prognosis is poor if diagnosis is delayed, in spite of recent treatment advances. Evidence is mounting that the incidence of melanoma is higher in the immunosuppressed and individuals with highly stressful occupations. We present a case series of individuals diagnosed with multiple cutaneous melanomas over a few months to 1 year. All had encountered psychological stressors in their lives, and the melanomas were diagnosed briefly after encountering these stressors. No known causes of immunosuppression were detected to explain the sporadic occurrence of melanomas in these individuals. There is evidence in the current literature that stress can lead to immune disregulation, predisposing an individual to various disease states including melanoma. Stress hormones such as norepinephrine have been shown to cause upregulation of cytokines such as Interleukin 6 and 8, which are proangiogenic and support tumour progression. Coupled with genetic and environmental factors, stress appears to play a role in melanoma formation and progression. Large prospective studies are required to study the link between stress and melanoma and gain further insight into the etiology of melanoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740369     DOI: 10.1007/s00403-013-1373-2

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  6 in total

Review 1.  Targeting the PD-1 pathway: a promising future for the treatment of melanoma.

Authors:  Andrew Mamalis; Manveer Garcha; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2014-03-11       Impact factor: 3.017

Review 2.  The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options.

Authors:  Roberta Colucci; Silvia Moretti
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-23       Impact factor: 4.553

3.  Inhibition of human melanoma growth by a non-cardioselective β-blocker.

Authors:  Ludovic J Wrobel; Frederique Anne Le Gal
Journal:  J Invest Dermatol       Date:  2014-09-01       Impact factor: 8.551

4.  Melanoma in situ: a case report from the patient's perspective.

Authors:  Craig A Bauman; Peter Emary; Tyler Damen; Heather Dixon
Journal:  J Can Chiropr Assoc       Date:  2018-04

Review 5.  Neuroendocrine factors: The missing link in non‑melanoma skin cancer (Review).

Authors:  Mihai Lupu; Ana Caruntu; Constantin Caruntu; Laura Maria Lucia Papagheorghe; Mihaela Adriana Ilie; Vlad Voiculescu; Daniel Boda; Carolina Constantin; Cristiana Tanase; Maria Sifaki; Nikolaos Drakoulis; Charalampos Mamoulakis; George Tzanakakis; Monica Neagu; Demetrios A Spandidos; Boris N Izotov; Aristides M Tsatsakis
Journal:  Oncol Rep       Date:  2017-07-13       Impact factor: 3.906

Review 6.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.